-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Find
New research from UCLA found that 30 percent of people treated for COVID-19 developed acute post-COVID-19 sequelae (PASC), the most common being the "long coronavirus
Among the 309 patients in the study with prolonged COVID-19 infection, the most persistent symptoms were fatigue and shortness of breath in hospitalized patients (31% and 15%, respectively), and loss of smell in outpatient patients (16%)
background
Throughout the pandemic, the incidence and risk factors for the long coronavirus, and even how the syndrome is defined, remain unclear
method
UCLA researchers studied 1,038 patients who presented to the UCLA COVID-19 outpatient clinic between April 2020 and February 2021
Potential weaknesses of the study include: the subjective nature of patient-assessed symptoms, the limited number of symptoms assessed by researchers, and limited information about patients' prior conditions
Influence
"This study demonstrates the need to follow different patient groups longitudinally to understand the trajectories of COVID-19 over time, and to assess individual factors such as pre-existing comorbidities, sociodemographic factors, vaccination status and types of viral variants, How it affects the type and persistence of COVID-19 symptoms over prolonged periods of time,
author
Additional authors of the study are Dr.
Magazine
journal of general internal medicine
DOI
10.
method research
observational study
research topic
people
article title
Factors associated with acute sequelae of SARS-CoV-2 (PASC) following inpatient and outpatient diagnosis of symptomatic COVID-19 in different cohorts
Article publication date
7 - April - 2022